Clinical Trials Directory

Trials / Completed

CompletedNCT04031534

Study of Hypoxia Measured in F-Miso PET/Scan and MRI in Patients With Squamous Cells Carcinoma

Comparative Study of Hypoxia Measured in F-Miso PET/Scan and MRI in Patients With Squamous Cells Carcinoma : Correlation With Immunohistochemistry

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Centre Henri Becquerel · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hypoxia imaging has not been studied extensively by combining PET and MRI data. Few studies performed the double imaging and none associated anatomopathology with it . This study will use a rigorous methodology through the production of PET/MRI images at the same time by transferring the patient directly from PET to MRI. In addition, the population, unlike other studies, will include preoperative patients with 24-hour surgery for hypoxia imaging by obtaining additional data through specific immunohistochemical analysis of hypoxia.

Conditions

Interventions

TypeNameDescription
DRUGF-Miso PET scan coupled with MRIPatient will undergo F-Miso PET and MRI before surgery for their head and neck cancer. Hypoxia detect with imaging will be correlated with hypoxia detected by immunohistochemistry on tumour biopsy

Timeline

Start date
2019-03-21
Primary completion
2021-08-06
Completion
2022-07-21
First posted
2019-07-24
Last updated
2026-01-02

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04031534. Inclusion in this directory is not an endorsement.

Study of Hypoxia Measured in F-Miso PET/Scan and MRI in Patients With Squamous Cells Carcinoma (NCT04031534) · Clinical Trials Directory